Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.

@article{Kong2008NovelRO,
  title={Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.},
  author={Juan Kong and Zhongyi Zhang and Mark W Musch and Gang Ning and Jun Sun and John Hart and Marc Bissonnette and Yan Chun Li},
  journal={American journal of physiology. Gastrointestinal and liver physiology},
  year={2008},
  volume={294 1},
  pages={
          G208-16
        }
}
  • J. Kong, Zhongyi Zhang, Y. Li
  • Published 2008
  • Medicine, Biology
  • American journal of physiology. Gastrointestinal and liver physiology
Emerging evidence supports a pathological link between vitamin D deficiency and the risk of inflammatory bowel disease (IBD). To explore the mechanism we used the dextran sulfate sodium (DSS)-induced colitis model to investigate the role of the vitamin D receptor (VDR) in mucosal barrier homeostasis. While VDR(+/+) mice were mostly resistant to 2.5% DSS, VDR(-/-) mice developed severe diarrhea, rectal bleeding, and marked body weight loss, leading to death in 2 wk. Histological examination… 

Figures and Tables from this paper

Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice

1,25(OH)2D3 may play a protective role in mucosal barrier homeostasis by maintaining the integrity of junction complexes and in healing capacity of the colon epithelium.

Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis

It is indicated that vitamin D attenuates the development of TNBS-induced colitis by inhibiting the apoptosis of IECs, the mechanisms involved include the downregulation of PUMA expression.

Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation.

It is demonstrated that vitamin D is an important mediator of intestinal epithelial defenses against infectious agents and predisposes to more-severe intestinal injury in an infectious model of colitis.

Implication of intestinal VDR deficiency in inflammatory bowel disease.

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.

It is demonstrated that gut epithelial VDR signaling inhibits colitis by protecting the mucosal epithelial barrier, and this anticolitic activity is independent of nonepithelial immune VDR actions.

Effects of Vitamin D-Deficient Diet on Intestinal Epithelial Integrity and Zonulin Expression in a C57BL/6 Mouse Model

This is the first study to demonstrate that VDD could lead to a significant upregulation in mRNA expression of the jejunum zonulin level and also a marked elevation of serum z onulin in a mouse model, and it is assumed that sufficient VD could maintain intestinal epithelial integrity and prevent mucosal barrier dysfunction.

Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis

Gut epithelial VDR deletion aggravates epithelial cell apoptosis, resulting in increases in mucosal barrier permeability, and depletion of gut commensal bacteria with antibiotics eliminated the robust TH1 and TH17 responses and CD11b+CD103+ DC induction.

Lack of Vitamin D Receptor Leads to Hyperfunction of Claudin-2 in Intestinal Inflammatory Responses.

A new role for intestinal epithelial VDR in regulating barrier functions in the context of infection and inflammation is identified and enhanced Claudin-2 promoter activity through the binding sites of NF-κB and STAT in inflamed VDR-/- cells is identified.

Does Vitamin D Protect the Gut Mucosal Barrier? Mechanistic Insights from Experimental Colitis

  • M. O'Sullivan
  • Medicine, Biology
    Digestive Diseases and Sciences
  • 2015
It is demonstrated that targeting epithelial VDR signaling mechanisms appears to reduce intestinal inflammation, and the assertion that this reduction in intestinal inflammation is a direct result of a VDR-mediated permeability reduction in the intestinal barrier is not supported based on the data presented.

Vitamin D/VDR signaling attenuates lipopolysaccharide-induced acute lung injury by maintaining the integrity of the pulmonary epithelial barrier

Vitamin D treatment alleviated LPS-induced lung injury and preserved alveolar barrier function, and therefore vitamin D treatment may present as a potential therapeutic strategy in ALI and acute respiratory distress syndrome.
...

References

SHOWING 1-10 OF 48 REFERENCES

Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury

A critical role is pointed to for the VDR and 1,25(OH)2D3 in control of innate immunity and the response of the colon to chemical injury in acute experimental IBD.

A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.

It is shown that VDR deficiency (knockout, KO) resulted in severe inflammation of the gastrointestinal tract in two different experimental models of IBD, establishing an essential role for VDR signaling in the regulation of inflammation in theintestinal tract.

Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.

The sigmoid colon of VDR-KO mice, fed on an appropriate lactose/calcium-enriched diet to alleviate impaired calcium homeostasis-related phenotypic changes, is an excellent model for investigating induction and prevention of pre-malignant changes in one of the hotspots for human colorectal cancer incidence.

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.

The vitamin D hypothesis was tested in an experimental animal model of inflammatory bowel disease (IBD) and it was found that supplementation with vitamin D significantly blocked the progression and ameliorated symptoms of IBD in IL-10 KO mice with already established IBD.

Mechanisms of Disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases

This new paradigm subverts traditional theories underlying the development of autoimmunity, which are based on molecular mimicry and/or the bystander effect, and suggests that the autoimmune process can be arrested if the interplay between genes and environmental triggers is prevented by re-establishing intestinal barrier function.

Increased gut permeability in Crohn’s disease: is TNF the link?

Impaired barrier function may precede the clinical development of the disease and might represent a marker of increased susceptibility to Crohn’s disease.

AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins.

It is suggested that AMP-18 could protect the intestinal mucosal barrier by acting on specific TJ proteins and stabilizing perijunctional actin during oxidant injury.

Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone.

GH does not alter susceptibility to acute DSS-induced colitis but enhances survival, remission of inflammation, and mucosal repair during recovery, suggesting GH therapy may be beneficial during active IBD by improving mucosal Repair.

Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor

A central role for ITF in the maintenance and repair of the intestinal mucosa is revealed and mice lacking ITF had impaired mucosal healing and died from extensive colitis after oral administration of dextran sulfate sodium.

Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium.

An increase in colonic mucosal permeability, leading to the destruction of mucosal barrier function, may play an important role in the induction of DSS-induced murine colitis.